This trial will test whether CBD can help reduce inflammation in the brain and help lessen pain sensitization.
1 Primary · 1 Secondary · Reporting Duration: 10 Days
Active Control
Non-Treatment Group
15 Total Participants · 2 Treatment Groups
Primary Treatment: CBD · Has Placebo Group · Phase < 1
Age 18 - 55 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Connecticut | 66.7% |
California | 33.3% |
18 - 65 | 100.0% |
Connecticut Mental Health Center | 100.0% |
Met criteria | 66.7% |
Did not meet criteria | 33.3% |